Relationship between circulating PCSK9 and markers of subclinical atherosclerosis—the IMPROVE study

Coggi, D. et al. (2021) Relationship between circulating PCSK9 and markers of subclinical atherosclerosis—the IMPROVE study. Biomedicines, 9(7), 841. (doi: 10.3390/biomedicines9070841) (PMCID:PMC8301759)

[img] Text
248209.pdf - Published Version
Available under License Creative Commons Attribution.



(1) Background and purpose: circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) is one of the key regulators of cholesterol metabolism. Despite this, its role as a player in atherosclerosis development is still matter of debate. Here, we investigated the relationships between this protein and several markers of subclinical atherosclerosis. (2) Methods: the IMPROVE study enrolled 3703 European subjects (54–79 years; 48% men; with ≥3 vascular risk factors), asymptomatic for cardiovascular diseases. PCSK9 levels were measured by ELISA. B-mode ultrasound was used to measure markers of carotid subclinical atherosclerosis. (3) Results: in the crude analysis, PCSK9 levels were associated with several baseline measures of carotid intima-media thickness (cIMT) (all p 0.0001); with cIMT change over time (Fastest-IMTmax-progr) (p = 0.01); with inter-adventitia common carotid artery diameter (ICCAD) (p 0.0001); and with the echolucency (Grey Scale Median; GSM) of both carotid plaque and plaque-free common carotid IMT (both p 0.0001). However, after adjustment for age, sex, latitude, and pharmacological treatment, all the afore-mentioned correlations were no longer statistically significant. The lack of correlation was also observed after stratification for sex, latitude, and pharmacological treatments. (4) Conclusions: in subjects who are asymptomatic for cardiovascular diseases, PCSK9 plasma levels do not correlate with vascular damage and/or subclinical atherosclerosis of extracranial carotid arteries.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Strawbridge, Dr Rona
Creator Roles:
Strawbridge, R. J.Resources, Visualization, Funding acquisition
Authors: Coggi, D., Frigerio, B., Bonomi, A., Ruscica, M., Ferri, N., Sansaro, D., Ravani, A., Ferrante, P., Damigella, M., Veglia, F., Capra, N., Lupo, M. G., Macchi, C., Savonen, K., Silveira, A., Kurl, S., Giral, P., Pirro, M., Strawbridge, R. J., Gigante, B., Smit, A. J., Tremoli, E., Amato, M., and Baldassarre, D.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Mental Health and Wellbeing
Journal Name:Biomedicines
ISSN (Online):2227-9059
Published Online:19 July 2021
Copyright Holders:Copyright © 2021 The Authors
First Published:First published in Biomedicines 9(7): 841
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
302131Understanding the excess risk of cardiometabolic disease in individuals with serious mental illnessJill PellMedical Research Council (MRC)MR/S003061/1HW - Public Health